RWPA
MRK icon

Richard W. Paul & Associates’s Merck MRK Stock Holding History

Richard W. Paul & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Sell
11,769
-391
-3% -$45.1K 0.48% 55
2025
Q4 		$1.28M Buy
12,160
+193
+2% +$18.1K 0.43% 63
2025
Q3 		$1M Sell
11,967
-289
-2% -$23.8K 0.34% 75
2025
Q2 		$970K Buy
12,256
+3,716
+44% +$295K 0.35% 69
2025
Q1 		$767K Sell
8,540
-2,745
-24% -$256K 0.3% 84
2024
Q4 		$1.12M Buy
11,285
+655
+6% +$67.5K 0.41% 65
2024
Q3 		$1.21M Buy
10,630
+1,094
+11% +$130K 0.43% 61
2024
Q2 		$1.18M Sell
9,536
-90
-0.9% -$11.6K 0.46% 51
2024
Q1 		$1.27M Sell
9,626
-85
-0.9% -$10.5K 0.51% 48
2023
Q4 		$1.06M Buy
9,711
+17
+0.2% +$1.76K 0.44% 58
2023
Q3 		$998K Buy
9,694
+305
+3% +$32.9K 0.46% 59
2023
Q2 		$1.08M Buy
9,389
+94
+1% +$10.7K 0.47% 58
2023
Q1 		$989K Sell
9,295
-1,868
-17% -$202K 0.46% 59
2022
Q4 		$1.24M Buy
+11,163
New +$1.14M 0.62% 38

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Richard W. Paul & Associates's MRK Position: Q1 2026 in Review

Richard W. Paul & Associates reduced its Merck (MRK) stake by 3.2% in Q1 2026, selling an estimated $45.1K and leaving 11,769 shares worth $1.42M. The position accounts for 0.48% of the portfolio, ranked #55.

Richard W. Paul & Associates first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Richard W. Paul & Associates held 11,769 shares of Merck worth $1.42M as of Q1 2026.
  • Richard W. Paul & Associates sold 391 Merck shares in Q1 2026, an estimated $45.1K.
  • Merck made up 0.48% of Richard W. Paul & Associates's portfolio in Q1 2026, its #55 holding.
  • Richard W. Paul & Associates first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Richard W. Paul & Associates's 13F filing for Q1 2026, filed 13 May 2026.